Torrent pharma successfully completes USFDA inspection for Levittown facility
Ahmedabad: Torrent Pharma has recently announced that the US Food and Drug Administration (USFDA) has successfully concluded inspection at its Levittown, Pennsylvania, USA manufacturing facility.
The inspection was conducted between 6th December 2021 and 15th December 2021.
"This is to inform that our Levittown, Pennsylvania, USA manufacturing facility was inspected by USFDA between 6 th December 2021 and 15th December 2021,"the company said in a BSE filing.
At the end of the inspection, No Form 483 was issued.
"It is a positive development for the Company and is a reflection of our commitment to consistency in quality and compliance with regulatory standards," the company added.
Read also: Torrent pharma gets CDSCO nod to market additional strength of Amlodipine,Olmesartan Medoxomil FDC
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.